Compounding pharmacies worried about potentially excessive federal oversight in the wake of the deadly meningitis outbreak could adopt a private accreditation model in conjunction with state regulators in an effort to head off congressional action.
The model could avoid many of the problems that plague efforts to give FDA more authority over the practice. But it also brings with it other potential problems, namely who...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?